Two weeks after Protein Sciences announced that it had begun producing the world's first swine flu vaccine, creditors of the company filed a petition for involuntary bankruptcy. The creditors claimed $11.7 million. Emergent BioSolutions struck a deal last May to buy Protein Sciences' assets for $28 million in cash and the assumption of a $20 million note. Report